Anne-Sophie de Faucigny

Public Communications Contact at GETLINK SE

Transportation

Consumer Services

Health Technology

Profile

Anne-Sophie de Faucigny is currently the Group Chief Communication Officer at Getlink SE.
Previously, she worked as the Director at Yposkesi from 2018 to 2021.
She is a graduate of Institut d’Études Politiques de Toulouse.

Anne-Sophie de Faucigny active positions

Companies	Position	Start
GETLINK SE	Public Communications Contact	30/09/2022

All active positions of Anne-Sophie de Faucigny

Former positions of Anne-Sophie de Faucigny

Companies	Position	End
Yposkesi Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The private company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021.	Director/Board Member	31/12/2020

See the detail of Anne-Sophie de Faucigny's experience

Training of Anne-Sophie de Faucigny

Institut d’Études Politiques de Toulouse

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anne-Sophie de Faucigny's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GETLINK SE	Transportation

Private companies	1
Yposkesi Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The private company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021.	Health Technology